Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9844606rdf:typepubmed:Citationlld:pubmed
pubmed-article:9844606lifeskim:mentionsumls-concept:C0007134lld:lifeskim
pubmed-article:9844606lifeskim:mentionsumls-concept:C0010802lld:lifeskim
pubmed-article:9844606lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:9844606lifeskim:mentionsumls-concept:C0524869lld:lifeskim
pubmed-article:9844606lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:9844606lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:9844606pubmed:issue2lld:pubmed
pubmed-article:9844606pubmed:dateCreated1998-12-10lld:pubmed
pubmed-article:9844606pubmed:abstractTextWe performed a study of loss of heterozygosity (LOH) at 3p by restriction fragment length polymorphism analysis in a series of 22 renal tumors. In 11 cases, molecular results could be compared with those of cytogenetic studies. The highest frequency of allelic losses at 3p was seen in clear cell non-papillary renal tumors, whereas none of the papillary renal cell carcinomas showed LOH at 3p. Allelic losses on 3p were found to be independent of tumor grade or stage or both. One case analyzed showed a discrepancy between cytogenetic and LOH studies. This tumor displayed rearrangements of chromosome 3 and no LOH at the c-RAF-1 (close to the Von Hippel Lindau gene) locus.lld:pubmed
pubmed-article:9844606pubmed:languageenglld:pubmed
pubmed-article:9844606pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844606pubmed:citationSubsetIMlld:pubmed
pubmed-article:9844606pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844606pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9844606pubmed:statusMEDLINElld:pubmed
pubmed-article:9844606pubmed:monthDeclld:pubmed
pubmed-article:9844606pubmed:issn0165-4608lld:pubmed
pubmed-article:9844606pubmed:authorpubmed-author:EgozcueJJlld:pubmed
pubmed-article:9844606pubmed:authorpubmed-author:MiróRRlld:pubmed
pubmed-article:9844606pubmed:authorpubmed-author:GelabertAAlld:pubmed
pubmed-article:9844606pubmed:authorpubmed-author:CaballínM RMRlld:pubmed
pubmed-article:9844606pubmed:authorpubmed-author:CasadevallCClld:pubmed
pubmed-article:9844606pubmed:authorpubmed-author:ChéchileGGlld:pubmed
pubmed-article:9844606pubmed:authorpubmed-author:BernuésMMlld:pubmed
pubmed-article:9844606pubmed:authorpubmed-author:EjarqueM JMJlld:pubmed
pubmed-article:9844606pubmed:issnTypePrintlld:pubmed
pubmed-article:9844606pubmed:volume107lld:pubmed
pubmed-article:9844606pubmed:ownerNLMlld:pubmed
pubmed-article:9844606pubmed:authorsCompleteYlld:pubmed
pubmed-article:9844606pubmed:pagination121-4lld:pubmed
pubmed-article:9844606pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:9844606pubmed:meshHeadingpubmed-meshheading:9844606-...lld:pubmed
pubmed-article:9844606pubmed:meshHeadingpubmed-meshheading:9844606-...lld:pubmed
pubmed-article:9844606pubmed:meshHeadingpubmed-meshheading:9844606-...lld:pubmed
pubmed-article:9844606pubmed:meshHeadingpubmed-meshheading:9844606-...lld:pubmed
pubmed-article:9844606pubmed:meshHeadingpubmed-meshheading:9844606-...lld:pubmed
pubmed-article:9844606pubmed:meshHeadingpubmed-meshheading:9844606-...lld:pubmed
pubmed-article:9844606pubmed:meshHeadingpubmed-meshheading:9844606-...lld:pubmed
pubmed-article:9844606pubmed:meshHeadingpubmed-meshheading:9844606-...lld:pubmed
pubmed-article:9844606pubmed:meshHeadingpubmed-meshheading:9844606-...lld:pubmed
pubmed-article:9844606pubmed:year1998lld:pubmed
pubmed-article:9844606pubmed:articleTitleAnalysis of 3p allelic losses in renal cell carcinomas: comparison with cytogenetic results.lld:pubmed
pubmed-article:9844606pubmed:affiliationInstitut de Biologia Fonamental, Universitat Autònoma de Barcelona, Spain.lld:pubmed
pubmed-article:9844606pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9844606pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed